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ABSTRACT N-type and L-type channels have signiﬁcant gating differences, and we wondered whether some of these differ-
ences are linked to the relationship between charge movement and channel opening. The time constants for N-channel closing
(tDeact) and Off-gating charge movement (tQOff) were compared over a range of voltages. tQOff was signiﬁcantly larger than
tDeact at voltages < 10 mV, and the voltage dependence of the tQOff was less steep than that for tDeact, which suggests
that gating charge relaxation does not limit channel closing. Roscovitine, a drug that slows N-channel closing by holding the
channel in a high open-probability state, was found to slow both tQOff and tDeact, and thus the time courses of channel closing
and gating charge relaxation were similar. Our gating current results were reproduced with the addition of a voltage-independent,
closed-closed transition to our previously published two-open-state N-channel model. This work suggests that, like L-type chan-
nels, there is a voltage-independent transition along the N-channel activation/deactivation pathway, but this transition occurs
between closed states instead of the closed-open states of the L-channel. Also unlike L-type channels, the gating charge
appears to be locked into the activated position by the N-channel open state.INTRODUCTION
Voltage-dependent calcium channels are crucial regulators
of neuronal function. However, our understanding of the
fundamental gating mechanisms of these channels has
lagged behind that of other voltage-dependent channels.
One reason for this is the limited number of gating modifiers
that exist for these channels, which is particularly true for the
CaV2 class (1). Roscovitine is a cyclin-dependent kinase
inhibitor that slows the closing of CaV2 channels (2–5).
We were able to reproduce the effect of roscovitine on
N-type calcium channels using a two-open-state gating
model, with roscovitine exclusively binding to the open
states and with the high open-probability (Po) state having
20 higher affinity for roscovitine (2). Although the rosco-
vitine-induced slowed deactivation was somewhat reminis-
cent of the BayK8644 effect on L-type (CaV1.2) channels,
there were significant differences. First, roscovitine can
only bind after the channel opens, and thus binds-unbinds
with every voltage step (2), whereas BayK8644 is constantly
bound to L-channels (6,7). Second, the high Po state to which
roscovitine preferentially binds is predicted to be part of
normal N-channel gating (2), whereas BayK8644 shifts
gating into a novel L-channel gating mode that is not typi-
cally achieved under control conditions (6,7). The effect of
both BayK8644 on L-channels and roscovitine on N-chan-
nels has greatly enhanced our understanding of calcium
channel gating.
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0006-3495/09/11/2446/10 $2.00Although BayK8644 induces a dramatic slowing of
L-channel deactivation, its effect on gating charge movement
is not so pronounced (8–10). The same BayK8644 concen-
tration that maximally slows L-channel deactivation slows
only a small fraction (~20%) of the L-channel Off-gating
current (8–10), which suggests that Off-gating charge
(QOff) movement may be not limited by L-channel closing.
Another L-channel agonist, FPL64176, has no effect on
the time course of L-channel QOff (11), which further
supports the idea that charge movement can be dissociated
from L-channel closing.
In an attempt to understand the fundamental properties of
N-channel gating, we used roscovitine to probe the link
between channel opening and gating charge movement.
One clue to suggest that this relationship would differ from
that of L-channels is that N-channels exhibit voltage-depen-
dent open times (12), whereas L-channel open times have
been shown to be voltage-independent (6,7). Thus, we antic-
ipated a different relationship between channel closing and
gating charge movement. We found that roscovitine signifi-
cantly slowed QOff relaxation, with relatively minor affects
on QOn kinetics. Our results were reproduced by our gating
model (described above) after significant modifications
were made, including the addition of two closed states
with a voltage-independent transition between them. The
existence of such a transition is supported by previous single
N-channel recordings (12). With this model, we were able to
explain differences between the voltage-dependence of
N-channel deactivation versus gating charge relaxation
under control conditions, and the coalescence of these values
by roscovitine. Our experimental and simulation results
support the notion that voltage sensors are immobilized by
the N-channel open state.
doi: 10.1016/j.bpj.2009.08.014
Modulation of N-Channel Gating Current 2447MATERIALS AND METHODS
HEK cell transfection
We used the calcium phosphate precipitation method to transfect HEK293
cells with N-channels as previously described (13). HEK293 cells were trans-
fected with cDNA plasmids pcDNA3 (Invitrogen, Carlsbad, CA) as follows:
11.5mgCaV2.2-CFP, 8.5mga2d, 5.5mgb2a subunits, 2.15mgTAG.CaV2.2-CFP
containedCFP encoding cDNA attached to the N-terminus ofa1B to visualize
transfected cells.
Measurement of currents
Cells were voltage-clamped using the whole-cell configuration of the patch-
clamp technique as previously described (1). The leak current was subtracted
online using aP/4 protocol for ionic currents andP/8 for gating currents.
All recordings were carried out at room temperature, and the holding poten-
tial was120 mV. Gating currents were recorded using 40–60% series resis-
tance compensation, leaving a maximum voltage-clamp error of <5 mV.
There was no correlation between gating current parameters and maximum
voltage error and/or series resistance.
Solutions
The internal pipette solution contained (in mM) 104 NMG-Cl, 14 creatine-
PO4, 6 MgCl2, 10 NMG-HEPES, 5 Tris-ATP, 0.3 Tris-GTP, and 10 NMG-
EGTA with osmolarity ¼ 280 mOsm and pH ¼ 7.4. The external recording
solution for ionic currents contained (in mM) 5 CaCl2, 145 NMG-Cl, and 10
NMG-HEPES with osmolarity ¼ 325 mOsm and pH ¼ 7.4. Gating currents
were isolated as previously described (1) using a lanthanum and magnesium
(La-Mg) external solution that contained (in mM) 0.2 LaCl3, 5 MgCl2,
0.1 NMG-EGTA, 145 NMG-Cl, and 10 NMG-HEPES with osmolarity ¼
325 mOsm and pH ¼ 7.4. Throughout the experiments, 100 mM R-roscovi-
tine was used to modulate both ionic and gating currents, and the control
external solution contained 0.2% DMSO to control for the vehicle concen-
tration of the roscovitine solutions. Test solutions were applied from a
gravity-fed perfusion system with an exchange time of 1–2 s.
Data analysis
Data were analyzed using IgorPro (WaveMetrics, Lake Oswego, OR)
running on a Macintosh computer. The voltage dependence of activation
(activation I/V) was measured from ionic tail currents (averaged over
0.3 ms) at 60 mV. Tail current measurement was taken 0.3 ms into the
60 mV step to allow for voltage clamp settling. Deactivation was deter-
mined from a protocol that consisted of 10 ms steps to þ60 mV, followed
by 22 ms steps to tail voltages ranging from 0 to 140 mV. Ionic tail
currents were fitted by a single exponential function to determine deactiva-
tion t (tDeact). The tDeact versus voltage relationship was fit by a single expo-
nential function to determine the tDeact voltage dependence (Ve). Small
steady-state step/tail currents introduced by the P/8 leak subtraction
protocol were measured at the end of the step/tail and subtracted from the
gating currents. The total charge moved by depolarization or repolarization
(QOn or QOff, respectively) was calculated by integrating gating currents
over the entire voltage step. The Off-gating current t (tQOff) was calculated
as for ionic current tDeact (as described above). The magnitude of Off-gating
currents was calculated by averaging 0.3 ms of current at the peak. Group
data were calculated as the mean 5SD throughout the study. A paired
t-test was used for within-cell comparisons. A one-way analysis of variance
with Tukey’s honestly significant difference (HSD) post hoc test was used to
test for differences among three or more independent groups.
Computer simulations
Simulated currents were generated using Axovacs 3 (written by Stephen W.
Jones, Case Western Reserve University, Cleveland, OH) on a MacintoshG3 computer running Virtual PC 6 (Microsoft, Seattle, WA). Voltage-
dependent rate constants (kx) in the model were calculated from
kx ¼ Ax expðVzxF=RTÞ;
where Ax is the rate constant at 0 mV, zx is the charge moved, and R, T, and
F are the gas constant, absolute temperature, and Faraday’s constant, respec-
tively. Simulated currents were analyzed using IgorPro, and simulated
gating currents were filtered using a digital RC filter at 2.3 kHz (R ¼
8.4 MU  0.6, C ¼ 15 pF) before measurement to reproduce the filtering
introduced by our average uncompensated series resistance (40%) and our
average cell capacitance.
Chemicals
All experiments utilized R-roscovitine from LC Labs (Woburn, MA). Dul-
becco’s modified Eagle’s medium (DMEM)/F12, DMEM, fetal bovine
serum, and 100 antibiotic/antimycotic were obtained from Invitrogen
(Carlsbad, CA). Other chemicals were obtained from Sigma (St. Louis, MO).
RESULTS
Effect of roscovitine on ionic currents
Roscovitine has been shown to affect multiple gating mecha-
nisms to either enhance or inhibit Caþ2 influx via N-type
calcium channels (2,14). The inhibitory effect of roscovitine
on step currents is caused by a negative shift in the voltage
dependence of closed-state inactivation (14), which can lead
to gating charge immobilization (15). However, voltage-
dependent inactivation is abrogated by coexpression of the
CaVb2a subunit (16), and our experiments revealed that coex-
pressing the b2a subunit with the N-channel eliminated the
inhibitory effect of roscovitine (Fig. 1, A and B). On average,
the current atþ10mV (peak of the I/V) was increased 21%5
10% (5 SD) by 100 mM roscovitine (n¼ 15), as opposed to
the inhibition we observed when these channels were ex-
pressed with CaVb1b (14). Roscovitine also induced a
10.4 5 3.7 mV (n ¼ 14) shift of the I/V V0.5 (Fig. 1 C),
which was larger than previously observed (2,3) and may
result from the elimination of inhibition by coexpression of
the b2a subunit. The roscovitine-induced slowed deactivation
was similar to what we have previously observed (2,3). We
conclude that coexpression of CaVb2a permits the study of
the roscovitine agonist effect without the complication of
roscovitine-induced inhibition.
Roscovitine left-shifts the Q/V relationship
Given the 10 mV left-shift in the I/V relationship, we were
interested in how roscovitine would affect the gating charge
versus voltage (Q/V) relationship. N-channel gating current
(La-Mg) activates ~20 mV negative to ionic currents (5 mM
Ca2þ), with some slight differences between QOn and QOff
that we have attributed to a small ionic current contamination
of QOff (1). Roscovitine induced a left-shift in the Q/V rela-
tionship with DV0.5 ¼ 3.55 2.4 mV for QOn and 4.35
2.6 mV for QOff (Fig. 2 C). No effect on the Boltzmann slope
factor was observed for either QOn/V or QOff/V (Fig. 2, BBiophysical Journal 97(9) 2446–2455
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a small (4.6% 5 4.5%) decrease in max QOn (n ¼ 11, p <
0.01) and a small increase in tQOn at voltages < 0 mV (see
Fig. 7F). This increase in tQOn is reminiscent of the increased
N-current activation t (tAct) observed over a similar voltage
range (see Fig. 7 E).
The effects of roscovitine on QOff were much more
dramatic, including a slowing of QOff relaxation, a decrease
FIGURE 1 Effect of roscovitine on N-channel ionic currents. (A) Repre-
sentative records show ionic currents in control (Cntl), 100 mM roscovitine
(Rosc, thick line), and washout (WO). The voltage protocol is shown below.
Roscovitine slightly increased the step current and dramatically slowed
deactivation. (B) Steady-state step current (5 mM Ca2þ) was plotted versus
voltage. (C) Ionic tail current (open symbols) and On-gating current (solid
symbols) were plotted against step voltage and fit using a single Boltzmann
equation to yield V0.5, slope factor, and maximum current, which were used
to normalize the data. The Boltzmann fitting parameters for ionic currents
are (Cntl, Rosc, and WO) V0.5 ¼ 11.8, 1.1, and 11.2 mV; and slope
factor ¼ 11.1, 8.7, and 11.0. For On-gating currents, they are V0.5 ¼
14.6, 18.6, and 15.8; and slope factor ¼ 7.6, 8.9, and 8.6.Biophysical Journal 97(9) 2446–2455FIGURE 2 Effect of roscovitine on the Q/V relationship. (A) Typical
traces show the voltage dependence of gating currents recorded in La-Mg;
100 mM roscovitine (black traces) slowed deactivation of Off-gating
currents compared to control (gray traces) at step voltages depolarized to
20 mV. (B) The effect of Rosc (squares) on QOn/V (On, solid symbols)
and QOff/V (Off, open symbols) compared to Cntl (circles) and WO (trian-
gles). The data were fitted by a single Boltzmann function (smooth lines)
to yield (Cntl, Rosc, WO) QOn V0.5 ¼ 12.3, 17.1 and 16.2 mV; slope
factor¼ 9.3, 9.6, and 10.9; Qmax¼ 0.25, 0.22, and 0.25 pC; and QOff V0.5¼
6.5, 15.3, and 10.9 mV; slope factor ¼ 12.0, 10.3; and 10.9, Qmax ¼
0.28, 0.45, and 0.29 pC. (C) Roscovitine-induced changes (DRosc) in V0.5
(DV0.5) and slope factor (DK) are not significantly different (n¼ 11) between
QOn (white bars) and QOff (black bars).
Modulation of N-Channel Gating Current 2449FIGURE 3 Roscovitine left-shifts the Q/V relationship. (A) Typical gating
currents obtained from two consecutive depolarizing steps in control (thin
line) and 100 mM roscovitine (Rosc, thick line). Currents are shown for three
step voltages (Vtest ¼ 120 mV (top), 5 mV (middle), and 80 mV
(bottom)). The second step voltage was always 80 mV. QOn1 and QOn2
are marked and represent On-gating charge movement during the first and
second steps, respectively. (B) QOn1 (solid symbols) and QOn2 (open
symbols) are plotted against Vtest for control (Cntl, circle) and 100 mM rosco-
vitine (square). The data are fitted by single Boltzmann functions (smooth
curves) with parameters for QOn1 (Cntl and Rosc) of V0.5 ¼ 1 and 4 mV,
and slope factor ¼ 13 and 13. Parameters for QOn2 (Cntl and Rosc) were
V0.5¼6 and9 mV, and slope factor¼ 8 and 11. (C) The mean differencein peak Off-gating current (IOff), and a significant increase in
the apparent max QOff (Fig. 2). The slowed QOff relaxation
suggests that roscovitine similarly affects gating charge
movement and deactivation. The reduced peak IOff is consis-
tent with the slowedQOff, since a given amount of charge that
is moved over a longer time will result in a smaller peak IOff.
However, the large roscovitine-induced increase in max QOff
(integrated Off-gating current) was unexpected. On average,
this increase was 73% 5 28% (n ¼ 11) at 60 mV. One
likely possibility is that the combination of a slowed channel
closing with the strong driving force at 60 mV generated
a significant ionic flux during our measurement of QOff in
roscovitine.
We (1) and others (17) previously concluded that QOn
appears to be less contaminated by ionic current, and we
used a two-pulse Q/V protocol (11) to determine the validity
of the DV0.5 measured from QOff. This protocol measures
the Q/V relationship as the reduction of QOn atþ80 mV after
10 ms steps to voltages ranging from 120 to þ80 mV
(Fig. 3). The advantages of this protocol are that roscovitine
will have 10 ms to bind (as for the QOff measurements), and
ionic current contamination will be minimal at þ80 mV. As
depicted in Fig. 3 A, QOn1 is equivalent to QOn of the
standard protocol (Fig. 2), whereas QOn2 is measured during
the subsequent step to þ80 mV. We found no significant
difference between V0.5 and slope factor in control, with
V0.5 ¼ 65 3 mV and 85 8 mV, and slope ¼ 115 2
and 105 3 for QOn1 and QOn2, respectively (n¼ 7). Consis-
tent with the results shown in Fig. 2, 100 mM roscovitine
significantly left-shifted the V0.5 for both QOn1 and QOn2,
with no change in the Boltzmann slope factor (Fig. 3 C).
Thus, roscovitine left-shifts the Q/V relationship (2–5
mV), but this shift is smaller than that for ionic currents
(10 mV).
Roscovitine inhibits the peak Off-gating current
The apparent ionic current contamination did not significantly
impact the effect of roscovitine on the Q/V relationship, but
this contamination could mediate the slowing of QOff. One
possibility is that this slowing results entirely from a roscovi-
tine-induced increase in contaminating ionic current, with
no effect on the gating current. However, the QOff relaxation
was best fit by a single exponential function in 100 mM rosco-
vitine (see Fig. 5 B), which suggests that if two components
existed, they decayed with a similar t. In addition, if roscovi-
tine increased ionic current contamination without an effect
on QOff, we would expect to observe an increase in peak
IOff instead of the observed inhibition (Fig. 2 A). This inhibi-
tion of peak IOff is expected from roscovitine-induced slowed
QOff, since the same amount of gating charge is moving as in
the control, but over a longer time. Thus, the reduction of
(5 SD) in V0.5 (DV0.5) and slope factor (DK) induced by roscovitine for
QOn1 (open bars) and QOn2 (solid bars).Biophysical Journal 97(9) 2446–2455
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of QOff.
Of interest, the currents in Fig. 2 A reveal that the roscovi-
tine-induced reduction in peak IOff is voltage-dependent and
correlated with the slowing of QOff. We examined this
further by measuring peak IOff at 60 mV (from the Q/V
protocol) in control (ICntl) versus roscovitine (IRosc) along
with tQOff. The tQOff versus voltage relationship showed
an increase with voltage, as would be expected if roscovitine
binding were limited by low Po at negative voltages (Fig. 4,
A and B). This change was mirrored by the IRosc/ICntl ratio
versus voltage relationship (Fig. 4 C), which was fit using a
single Boltzmann equation to quantify V0.5 ¼ 18 mV
(slope factor ¼ e-fold for 9 mV). The negative V0.5
suggests that significant gating current modulation can occur
at voltages with relatively low Po. This along with the strong
correlation between slowed QOff and inhibited IOff supports
the conclusion that gating current relaxation is slowed by
roscovitine.
Similar deactivation and Off-gating current time
courses in roscovitine
As we demonstrated previously (2), roscovitine slows ionic
current deactivation at all voltages, which is accompanied
by a decreased voltage dependence (Ve) of deactivation t
(tDeact) (Fig. 5). We therefore investigated the tQOff Ve to
obtain a better understanding of the relationship between
tQOff and tDeact. As noted above, tQOff was determined by
single exponential fitting (Fig. 5B). Under control conditions,
tQOff was larger than tDeact, which suggests that channel
closing is not limited by charge movement. Roscovitine
slowed the QOff kinetics such that tQOff was nearly identical
to tDeact over all voltages examined (Fig. 5 C). However,
there was a trend for tQOff to be larger than tDeact at voltages
< 90 mV, which resulted in a larger Ve for tQOff versus
tDeact in roscovitine (Fig. 5 D). The correspondence between
tQOff and tDeact suggests that charge movement becomes
tightly coupled to channel closing in roscovitine.
Our initial analysis of QOff in roscovitine (Fig. 2) revealed
significant ionic current contamination, which could explain
the similar tQOff and tDeact values. If QOff is slowed by
roscovitine, we should be able to observe this as a slowed
recovery of QOn atþ60 mV (QOn2) after a strong depolariza-
tion (QOn1) (Fig. 6). The depolarization to the apparent
reversal potential (þ60 mV for La-Mg) would limit ionic
current contamination for better gating current isolation.
A plot of QOn2 versus the time interval between pulses
(Fig. 6 C) was fit by a single exponential function to deter-
mine tQOn2 at interval voltages of 40 mV, 60 mV, and
80 mV. tQOn2 closely corresponded with tQOff, such
that the values were superimposed for each voltage in both
control and roscovitine (Fig. 6 D). We conclude that rosco-
vitine slows channel closing and thus becomes rate-limiting
to gating charge relaxation.Biophysical Journal 97(9) 2446–2455N-channel model
Our experimental results support the hypothesis that roscovi-
tine stabilizes a high Po state to prevent gating charge
FIGURE 4 Effect of roscovitine on the kinetics and magnitude of
Off-gating currents. (A and B) Representative gating current traces in Cntl
(thin line) and 100 mM Rosc (thick line) are shown for 20 mV (A) and
þ20 mV (B) step voltages. (C) tQOff is plotted versus step voltage from
Cntl (open circles), Rosc (solid squares), and WO (open triangles) (n¼ 10).
(D) IRosc/ICntl is plotted versus step voltage to show the voltage-dependent
decrease of IOff in Rosc (n ¼ 10). ICntl is the peak IOff averaged from
Cntl and WO, and IRosc is the peak IOff measured in the presence of
100 mM Rosc.
Modulation of N-Channel Gating Current 2451FIGURE 5 Effect of roscovitine on Off-gating current
relaxation. (A and B) Typical ionic (A) and gating (B)
current traces recorded in Cntl (thin line) and Rosc (thick
line) at 40 mV and 80 mV tail voltages. The smooth
gray lines superimposed on the tail and QOff currents are
from a single exponential fit to those currents. (C) Ionic
tail current tDeact (open symbols, n ¼ 12) and tQOff (solid
symbols, n ¼ 11) were calculated by single exponential
fitting (see panel A) and are plotted versus tail voltage for
Cntl (circles), Rosc (squares), and WO (triangles). The
smooth lines show the single exponential fitting to yield
Ve. (D) The bar graphs show the mean Ve (5SD) for tDeact
(ICa) and tQOff (QOff). The significant differences for all
comparisons were determined using analysis of variance
with Tukey’s HSD post hoc test (**p < 0.01). The lower-
case letters above each column indicate significant differ-
ences (n ¼ 11).relaxation. We tested this hypothesis using our previously
published seven-state model (Scheme 1) (2):
However, this model was only able to qualitatively repro-
duce our gating current results. For control simulations with
Scheme 1, the Q/V relationship was left-shifted relative to
the I/V relationship, but only by 10 mV (as opposed to the
20 mV observed in our recordings), and although tQOff
was larger than tDeact, the tQOff Ve and tDeact Vewere similar
(1). For the roscovitine simulations, the QOff kinetics were
dramatically slowed, such that tQOff was nearly identical
to tDeact, but in general, all model kinetic parameters were
too fast compared to our experimental results. Although
manipulation of the model parameters could overcome
some of these problems, the 20 mV shift between the control
Q/V and I/V relationships was difficult to obtain, and the
control tDeact Ve and tQOff Ve were always similar. One
clue as to how to address these issues came from the apparent
plateau of control tQOff at voltages < 80 mV, which sug-
gested a voltage-independent step within the activation/deac-
tivation pathway. The addition of a voltage-independent
transition between C4 and C5 (Fig. 7 A) lowered the control
tQOff voltage dependence without affecting the tDeact Ve andprovided excellent correspondence with our experimental
results (Fig. 7 D). We addressed the 20 mV shift in the
control Q/V versus I/V relationships by adding two addi-
tional closed states and increasing the charge moved by
voltage-dependent closed-closed transitions from 0.8–0.9
(Scheme 1) (2) to 1 (Scheme 2, Fig. 7). Since the open states
in these models are voltage-dependent, a large fraction of
charge was moved by these transitions in Scheme 1 (three
closed states versus two open states), which severely limited
the magnitude of the achievable shift between the Q/V and
I/V relationships. With the additional closed states and
increased charge (Scheme 2, Fig. 7), we were able to achieve
excellent correspondence with our control experimental Q/V
relationship (Fig. 7 C). We also were able to nicely repro-
duce the control tAct versus voltage relationship (Fig. 7 E)
and obtain decent correspondence with the tQOn versus
voltage relationship (Fig. 7 F).
The addition of 100 mM roscovitine to Scheme 2 in Fig. 7
induced a ~10 mV left-shift in the I/V relationship and
a much smaller shift in the Q/V relationship, nicely reproduc-
ing our experimental results (Fig. 7 C). The simulated tDeact
and tQOff were similar in roscovitine, but both were slightly
lower than our experimental values (Fig. 7 D). We were
able to increase these values, but that introduced an unaccept-
ably slow activation of ionic currents and yielded tAct values
in roscovitine that were too large. Thus, we compromised to
achieve good correspondence of both tAct (Fig. 7E) and tDeact
with our experimental data. We also found a small
roscovitine-induced increase in tQOn at voltages near zero,
but this increase was not as large as that in our experimental
data (Fig. 7 F). Finally, we observed a voltage-dependent
increase in tQOff (at 40 mV) and decrease of peak IOffBiophysical Journal 97(9) 2446–2455
2452 Yarotskyy and ElmslieFIGURE 6 Roscovitine slows QOn2 recovery. (A and B) Typical traces
show QOn2 recovery with increasing time interval between QOn1 and QOn2
in Cntl (A) and 100 mM Rosc (B). The voltage protocols are shown at the
bottom. (C) QOn2 is plotted versus the interval between QOn1 and QOn2
(DT) to show the QOn2 recovery time course in Cntl (open circle) and
Rosc (solid circles). The interval (tail) voltage was 60 mV, and these
data are from the same cell shown in panels A and B. The recovery time
course was fitted by a single exponential function to yield tQOn2. (D) Aver-
aged tQOn2 data (solid symbols) are superimposed with tQOff (open
symbols) from Fig. 5 C. Data are shown for Cntl (circle), Rosc (squares),Biophysical Journal 97(9) 2446–2455(Fig. 7, G and H) in roscovitine, which were similar to our
experimental results. The revised model reproduces
N-channel ionic and gating currents under control conditions,
and all elements of the roscovitine effect on these currents,
fully supporting our conclusion that gating charge cannot
move until the channel exits the high Po state.
DISCUSSION
Our fundamental finding is that roscovitine slows Off-gating
charge movement of N-type channels, with only minor
effects on On-charge movement. We conclude that roscovi-
tine unbinding is a rate-limiting step for Off-gating current
relaxation, and that the gating charge is immobilized by
N-channel occupancy of the high Po state.
Gating current isolation
Our group (1) and the Yue laboratory (17,18) previously
demonstrated that Mg2þ and a free La3þ concentration of
100 mM (200 mM La3þ and 100 mM EGTA) generated
good gating current isolation. One benefit of La-Mg is that
the Q/V relationship is not affected by an equimolar
exchange between Caþ2 and Mg2þ (17,18), which suggests
that these two divalent cations have a similar effect on the
N-channel response to membrane surface charge (19).
Thus, the voltage dependence of charge movement recorded
in La-Mg is directly comparable to the voltage-dependent
activation of ionic currents recorded in Ca2þ (1,17,18).
Although the La-Mg method of gating current isolation
was not perfect, we found that the contaminating ionic
current under control conditions was generally small and
manageable (1). In roscovitine, however, ionic current
contamination appeared to be a larger problem, which likely
resulted from the slowed channel closing (2) that allowed
significant ion conductance at the hyperpolarized potentials
used to measure QOff. This contamination was observed as
an increase in max QOff that likely resulted from Mg
2þ
permeation. Inorganic calcium channel blockers have been
shown to permeate calcium channels at potentials where
the driving force is large (20), and we have found obvious
Mg2þ permeation via expressed N-channels (b2a þ a2d) in
preliminary experiments. The 100 mM free La3þ in our
gating current solutions normally blocks Mg2þ permeation,
but that block is apparently partially cleared from the channel
at hyperpolarized voltages (20). However, the key findings
of our work that depend on QOff were verified by additional
experiments that examined the roscovitine effect on QOn
after a preceding voltage step. In addition, our simulation
results further support the roscovitine-induced effects on
gating charge movement.
and WO (triangles). All results are shown as mean5 SD. Number of cells
tested for tQOn2: n ¼ 3–8.
Modulation of N-Channel Gating Current 2453FIGURE 7 N-channel gating model reproduces the
effect of roscovitine on both ionic and gating current. (A)
The model (Scheme 2) for these simulations (see Table 1
for transition rates and charge moved). The asterisk by
k45 and k54 indicates the voltage-independent transition.
(B) Gating currents at 60 mV after a 10-ms step to
þ60 mV were simulated by running the model with
(Rosc) and without (Cntl) 100 mM roscovitine. (C)
A comparison of the I/V and QOn/V relationships for simu-
lations with (solid symbols) and without (open symbols)
Rosc. The I/V (circles) and QOn/V (squares) data were
measured during repolarization to 40 mV after 15-ms
steps to the voltages indicated on the x-axis. The symbols
have the same meaning in panels D–G. The smooth curves
are Boltzmann fits to the normalized experimental data
averaged from 11 cells for the Cntl I/V, Rosc I/V, Cntl
QOn/V and Rosc QOn/V. (D) Simulated ionic current tDeact
(circles) and gating current tQOff (squares) are plotted
versus repolarization voltage. Currents were activated by
a 10 ms step to þ60 mV and measured at the voltage indi-
cated on the x-axis. The smooth lines are single exponential
fits to the experimental data from Fig. 5 C. (E) tAct was
determined by single exponential fitting of the activation
phase of ionic current from the same protocol used to
generate the I/V relationship (C) and is plotted versus
step voltage. The thin line represents tAct measured from
experimental data in Cntl and Rosc. (F) tQOn was deter-
mined by single exponential fitting of the decay phase of
simulated On-gating current from the same protocol used
to generate the Q/V relationship (C) and is plotted versus
step voltage. The thin line represents tQOn measured
from experimental data in Cntl and Rosc. (G) tQOff was
measured from the same protocol used to generate the
Q/V relationship and is plotted versus step voltage. The thin
line represents the experimental data shown in Fig. 4 C.
(H) Peak Off-gating current was measured from simulated
gating current with (IRosc) or without (ICntl) roscovitine at
40 mV after voltage steps ranging from 40 to þ70 mV
(the sameprotocol as in panelC).The IRosc/ICntl ratio is plotted
versus step voltage. The smooth line is the single Boltzmann
equation fit to the experimental IRosc/ICntl versus voltage data
from Fig. 4 D.Voltage-independent transition in the activation/
deactivation pathway
The addition of a voltage-independent transition to our model
allowed us to reproduce our experimental ionic and gating
current results. By placing this transition between closed
states, we exerted little or no effect on the simulated ionic
currents, but we found it possible to model the lower tQOff
voltage dependence relative to that of tDeact in control. The
inclusion of this transition is supported by our observation
that tQOff appears to approach an asymptote at voltages <
80 mV, which suggests a voltage-independent rate-limiting
step. The voltage-independent transition must be between
closed states, since we have never observed a plateau for
tDeact at negative voltages, which suggests that this transitiondoes not limit channel closing. In addition, single N-channel
recordings revealed voltage-dependent open times that
strongly support voltage-dependent open states (12). How-
ever, the voltage-independent transition must be near the
open state, since the majority of gating charge movement is
limited by this transition. This location is also supported by
single-channel recordings that revealed a voltage-indepen-
dent closed time that became more prominent with depolar-
ization and was concluded to represent a voltage-independent
closed state near the open state (12). A potential physiolog-
ical consequence is that action potential-induced N-channel
opening could be delayed by the voltage-independent step
until the membrane voltage repolarizes into a range in which
the driving force is sufficiently strong to efficiently moveBiophysical Journal 97(9) 2446–2455
2454 Yarotskyy and ElmslieCaþ2 into the neuron to trigger neurotransmitter release and
activate intracellular signaling pathways (21).
Roscovitine affects the voltage dependence
of gating currents
Roscovitine left-shifts the I/V relationship, which we previ-
ously attributed to a mass-action effect of the channel being
‘‘locked’’ in the open state once roscovitine has bound (2).
At voltages where the channels have an intermediate Po,
roscovitine will increase the fraction of open channels by
‘‘trapping’’ them in an open state from which exit is slow.
This results in an increase in current at intermediate voltages,
with little or no effect on current amplitude at strong depolar-
izations where Po is maximal (Fig. 1). This same open-state
trapping mechanism likely explains the roscovitine-induced
small left-shift of the Q/V relationship and the increase of
tQOn at voltages near 0 mV, which is reminiscent of the
effect of roscovitine on the N-current tAct (2). We verified
this small roscovitine-induced left-shift in the QOff/V rela-
tionship using our QOn1-QOn2 protocol, and the model nicely
reproduced the small shift.
The model also reproduced the voltage-dependent effect
of roscovitine to increase tQOff and decrease peak IOff.
Roscovitine has little effect on these parameters at hyperpo-
larized voltages where Po is low, and the effect increases
with depolarization. There was a strong correlation between
the roscovitine-induced change in tQOff and IOff, indicating
that the two were linked as expected. We conclude that the
inhibition of IOff results from the slowing of QOff relaxation
so that the same charge movement is spread over a larger
area (thus the smaller IOff), and this conclusion is strongly
supported by our model.
TABLE 1 Rate parameters for the N-channel model (Scheme 2
in Fig. 7)
A z
k12 800 1
k21 200 1
k23 2200 1
k32 800 1
k34 2500 1
k43 2000 1
k45 3000
k54 5000
k56 1800 0.8
k65 2000 0.8
k67 1100 0.6
k76 900 0.6
k68 4[R]
k86 2000
k79 4[R]
k97 150
k89 1000 0.6
k98 61.37 0.6
A (s1) is the rate constant at 0 mV, z is the charge moved, and [R] is the
roscovitine concentration (mM). The units of A for k68 and k79 are mM1s1.Biophysical Journal 97(9) 2446–2455N-channels closing limits Off-gating current
relaxation
Under control conditions, tQOff was larger than tDeact indi-
cating that channel closing is not limited by gating charge
movement. However, in the control, it was more difficult
to determine whether the opposite was true. Our model
shows that the gating charge is immobilized as long as the
channel is in the high Po state. However, under control
conditions, the transition out of this state is sufficiently fast
that tQOff is not obviously impacted. One clue to suggest
that charge movement is linked to channel closing is that
in our experimental data, control tDeact and tQOff were
similar at 10 mV, where deactivation may be slow enough
(tDeact ~ 1 ms) to impact gating current relaxation (Fig. 5 C).
This link was further supported by roscovitine, which suffi-
ciently slowed channel closing so that tDeact and tQOff were
similar at all deactivation voltages. In our model, movement
out of the roscovitine-bound high Po state (RO9) occurs
via both the voltage-dependent RO9/ RO8 transition and
the roscovitine-unbinding RO9 / O7 transition, with the
RO9 / RO8 transition dominating at negative voltages.
These transitions are sufficiently slow to limit both tDeact
and tQOff so that the two processes have similar values. It
is important to note that in our experimental data, tDeact in
roscovitine was >1 ms at all voltages examined, which
was the value showing correspondence between tQOff and
tDeact in control (10 mV). Thus, we believe that voltage
sensor immobilization is tied to the open state, and not
roscovitine binding/unbinding per se. We conclude that the
N-channel must exit the high Po state before the gating
charge can relax back to the resting state.
We do not yet know where roscovitine binds to achieve its
effect on deactivation, but the binding site appears to play a
critical role in controlling the N-channel open state. The
L-channel agonist BayK8644 binds to a site comprised of
amino acids in domains III and IV, and the site appears to
be accessible via the membrane (22,23). We have argued
that the roscovitine-binding site is directly accessible to the
extracellular solution, and this conclusion is consistent with
all our available data (2,3). Thus, roscovitine likely binds to a
unique, extracellularly exposed site on the N-channel to slow
deactivation and voltage sensor relaxation.
The effect on the N-channel gating charge movement
appears to distinguish roscovitine from the L-channel
agonists BayK8644 and FPL64176, which dramatically
slow L-channel closing but have a relatively minimal impact
on QOff kinetics (8–11). Indeed, FPL64176 has no detectable
effect on the speed of QOff (9,11). Therefore, L-channels can
remain open even after the voltage sensors return to the
resting state (8,9,11). FPL64176 mechanism has been
proposed to involve a novel conducting state that permits
voltage sensor relaxation without channel closing (11). The
mechanism by which BayK8644 dissociates charge move-
ment from channel closing is unknown, but it is possible
Modulation of N-Channel Gating Current 2455that this is a fundamental L-channel property. The Monod-
Wyman-Changeuax model for L-channel gating predicts
voltage sensor relaxation from open L-channels (7). Thus,
BayK8644 and roscovitine can be used as tools to probe
the fundamental relationships between charge movement
and channel opening/closing, and to reveal the unique prop-
erties of these two closely related calcium channels. It is
possible that this voltage sensor relaxation is linked to
another difference between these two channels, which is
that the L-channel open state is voltage-independent (6,7),
whereas N-channels show voltage-dependent open times
(12). The activated confirmation of the L-channel may disso-
ciate open-closed gating from charge movement, whereas
the activated N-channel confirmation seem to be linked to
charge movement so that some charge movement is required
for open-open transitions and no voltage sensor relaxation
can occur until the channel closes. One crucial question is,
how are such gating differences achieved between these
homologous calcium channels?
Open-state modulation as a potential
pharmaceutical target
We recently showed that u-conotoxin GVIA is a gating
modifier that appears to destabilize the N-channel open state
by increasing the exit rates from and decreasing the entry
rates into both open states (1). Our modeling predicts that
this destabilization would result in a maximal 50% inhibition
of N-current if it could be separated from the pore-blocking
effect of the toxin. Roscovitine, on the other hand, stabilizes
open-state occupancy (2,3). Together, these two compounds
permit one to modulate the N-channel open state over a wide
range to investigate potential physiological and pathophysi-
ological effects, as well as the possible impact of reduced (by
u-conotoxin GVIA-like drugs) or enhanced (by roscovitine-
like drugs) N-channel activity on disease.
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